Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
FiercePharma10h
Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
FierceBiotech3d
Novo Nordisk to sue KBP Biosciences over alleged fraudulent claims on kidney disease drug
After its potential kidney disease drug went down in flames late last year, Novo Nordisk is pinning the blame on alleged ...
pharmaphorum2d
When licensing deals go bad - Novo sues KBP Bio for $830m
A lawsuit filed in the Singapore International Commercial Court is seeking $830 million in damages from KBP, with Novo ...
The Pharma Letter2d
Novo Nordisk sues KBP over claim it was ‘misled’ into deal
Danish pharma major Novo Nordisk has sued KBP Biosciences and its founder and executive chairman, Huang Zhenhua, for $830 ...
Singapore biotech tycoon Huang Zhenhua has assets frozen over $1.1 billion suit by pharma giant
Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at ...
Asia One1d
Singapore company sued by Novo Nordisk over $1.7b hypertension drug deal
Novo Nordisk is seeking up to US$830 million (S$1.1 billion) in damages from KBP Biosciences, according to a ruling by a Singapore court, as the Danish drugmaker says it was misled when it bought a ...
Business Times2d
All assets of biotech founder in Novo Nordisk suit frozen, including US$218 million in DBS account
PHARMA giant Novo Nordisk has been granted an injunction by the Singapore International Commercial Court to freeze the ...
Business Times2d
Singapore court freezes worldwide assets in US$830 million Novo Nordisk suit
PHARMA giant Novo Nordisk has been granted an injunction by the Singapore International Commercial Court to freeze the ...
Singapore biotech tycoon Huang Zhenhua has assets frozen over US$830mil suit by pharma giant
Pharmaceutical giant Novo Nordisk is seeking as much as US$830 million (S$1.1 billion) in damages in an application to a ...
Malay Mail on MSN21h
Singapore biotech tycoon Huang Zhenhua’s assets frozen over US$830m suit after misleading Novo Nordisk on ‘new and effective’ hypertension drug, court rules
Danish pharmaceutical giant Novo Nordisk has secured a court order to freeze the worldwide assets of Singapore-based KBP Biosciences and its founder Huang Zhenhua, amid a legal battle over an ...